C12N 9/641
Cysteine endopeptidases
Official title: {Cysteine endopeptidases (3.4.22)}
C12N9/641 (Cysteine endopeptidases) appears on 92 US grants and 85 published applications in this corpus.
Search patents in C12N- Granted patents
- 92
- Published applications
- 85
- Assignees
- 70
- Inventors
- 251
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 9 | 0 |
| 2002 | 4 | 5 |
| 2003 | 4 | 4 |
| 2004 | 3 | 1 |
| 2005 | 2 | 4 |
| 2006 | 0 | 3 |
| 2007 | 2 | 4 |
| 2008 | 2 | 5 |
| 2009 | 3 | 1 |
| 2010 | 5 | 7 |
| 2011 | 3 | 2 |
| 2012 | 4 | 1 |
| 2013 | 4 | 1 |
| 2014 | 0 | 4 |
| 2015 | 0 | 0 |
| 2016 | 2 | 0 |
| 2017 | 1 | 2 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 2 | 5 |
| 2021 | 2 | 6 |
| 2022 | 2 | 2 |
| 2023 | 2 | 2 |
| 2024 | 4 | 9 |
| 2025 | 3 | 7 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNA-guided nuclease15 Sep 2026US 12,735,691 B1Inari Agriculture Technology, Inc.
- Molecules and methods for iterative polypeptide analysis and processing9 Dec 2025US 12,493,042 B2Washington University
- Anti-microbial and UV-protective extracts and methods of making and using thereof4 Nov 2025US 12,460,212 B2Biocapital Holdings, LLC
- Means and methods for single molecule peptide sequencing23 Sep 2025US 12,422,438 B2Universiteit Gent
- Protease variants and uses thereof29 Oct 2024US 12,129,499 B2Seismic Therapeutic, Inc.
- Means and methods for single molecule peptide sequencing16 Jul 2026US 2026/0202416 A1Universiteit Gent
- Methods of treatment comprising igg antibodies and an ides protease5 Mar 2026US 2026/0062496 A1
- Improved igg-degrading enzymes and methods of use thereof29 Jan 2026US 2026/0028610 A1AstraZeneca Ireland Limited
- Ert2 mutants, inducible cell death systems, and uses thereof22 Jan 2026US 2026/0022364 A1Senti Biosciences, Inc.
- Anti-microbial and uv-protective extracts and methods of making and using thereof8 Jan 2026US 2026/0009039 A1Biocapital Holdings, LLC
Most cited
By later US patents
- Molecules and methods for iterative polypeptide analysis and processing57US 9,435,810 B2Washington University · 2016
- IdeS, an IgG-degrading enzyme of Streptococcus pyogenes40US 7,666,582 B2Hansa Medical Research AB · 2010
- Flea midgut-supernatant vaccines31US 5,356,622 AParavax, Inc. · 1994
- Relatedness of human interleukin-1.beta. convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor18US 5,962,301 AMassachusetts Institute of Technology · 1999
- Molecules and methods for iterative polypeptide analysis and processing16US 10,852,305 B2Washington University · 2020